Nisa Investment Advisors’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $63.5K | Sell |
3,966
-60
| -1% | -$960 | ﹤0.01% | 1532 |
|
|
2025
Q1 | $68.8K | Buy |
4,026
+17
| +0.4% | +$291 | ﹤0.01% | 1494 |
|
|
2024
Q4 | $99.3K | Buy |
4,009
+127
| +3% | +$3.15K | ﹤0.01% | 1475 |
|
|
2024
Q3 | $111K | Buy |
3,882
+44
| +1% | +$1.25K | ﹤0.01% | 1419 |
|
|
2024
Q2 | $101K | Buy |
3,838
+41
| +1% | +$1.08K | ﹤0.01% | 1475 |
|
|
2024
Q1 | $123K | Buy |
3,797
+38
| +1% | +$1.23K | ﹤0.01% | 1414 |
|
|
2023
Q4 | $158K | Sell |
3,759
-100
| -3% | -$4.21K | ﹤0.01% | 1326 |
|
|
2023
Q3 | $148K | Hold |
3,859
| – | – | ﹤0.01% | 1390 |
|
|
2023
Q2 | $73.2K | Buy |
3,859
+270
| +8% | +$5.12K | ﹤0.01% | 1614 |
|
|
2023
Q1 | $56K | Sell |
3,589
-2,250
| -39% | -$35.1K | ﹤0.01% | 1683 |
|
|
2022
Q4 | $104K | Buy |
5,839
+39
| +0.7% | +$695 | ﹤0.01% | 1544 |
|
|
2022
Q3 | $59K | Buy |
5,800
+1,000
| +21% | +$10.2K | ﹤0.01% | 1684 |
|
|
2022
Q2 | $19K | Buy |
4,800
+4,400
| +1,100% | +$17.4K | ﹤0.01% | 2058 |
|
|
2022
Q1 | $2K | Sell |
400
-3,620
| -90% | -$18.1K | ﹤0.01% | 2342 |
|
|
2021
Q4 | $28K | Sell |
4,020
-2,880
| -42% | -$20.1K | ﹤0.01% | 1867 |
|
|
2021
Q3 | $60 | Buy |
6,900
+6,500
| +1,625% | +$57 | ﹤0.01% | 1892 |
|
|
2021
Q2 | $4 | Hold |
400
| – | – | ﹤0.01% | 2284 |
|
|
2021
Q1 | $6 | Sell |
400
-1,300
| -76% | -$20 | ﹤0.01% | 2250 |
|
|
2020
Q4 | $79K | Buy |
+1,700
| New | +$79K | ﹤0.01% | 1833 |
|